The global DNA microarray market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for DNA microarrays in various applications such as gene expression, genotyping usage, genome cytogenetics and others.
The global DNA microarray market is segmented on the basis of type into oligonucleotide DNA microarrays (oDNA) and complementary DNA microarrays (cDNA). Oligonucleotide DNA Microarrays are expected to account for a larger share in the global market due to their high sensitivity and specificity. Complementary DNA Microarrays are also used extensively in research laboratories due to their low cost and ease of use.
On the basis of application, the global market is segmented into gene expression, genotyping usage, genome cytogenetics and others. Gene expression accounted for a major share in 2017 owing to its wide range of applications such as drug discovery & development, cancer research & diagnosis etc, which has led to an increase in demand for these products across various industries globally. Genotyping usage accounted for a significant share owing to its wide range of applications such as genetic testing services providers like 23andMe Inc, Myriad Genetics Inc, Illumina Inc, etc, which have led to an increase in demand for these products across various industries globally.
Some Of The Growth Factors Of This Market:
- The increasing demand for personalized medicine and the need for accurate diagnosis are driving the growth of this market.
- The increasing number of research and development activities in this field is also driving the growth of this market.
- Increasing government funding for research and development activities in this field is also driving the growth of this market.
- Increasing awareness about DNA microarrays among healthcare professionals, patients, and academia.
Industry Growth Insights published a new data on “DNA Microarray Market”. The research report is titled “DNA Microarray Market research by Types (Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA)), By Applications (Gene Expression, Genotyping, Other Usage, Genome Cytogenetics, ), By Players/Companies Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology, Savyon Diagnostics, Scienion AG, WaferGen, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Microarray Market Research Report
By Type
Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA)
By Application
Gene Expression, Genotyping, Other Usage, Genome Cytogenetics,
By Companies
Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology, Savyon Diagnostics, Scienion AG, WaferGen,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global DNA Microarray Market Report Segments:
The global DNA Microarray market is segmented on the basis of:
Types
Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gene Expression, Genotyping, Other Usage, Genome Cytogenetics,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumnia
- Affymetrix
- Agilent Technologies
- Roche NimbleGen
- Sengenics
- Arrayit
- Applied Microarrays
- Biometrix Technology
- Savyon Diagnostics
- Scienion AG
- WaferGen
Highlights of The DNA Microarray Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oligonucleotide DNA Microarrays (oDNA)
- Complementary DNA Microarrays (cDNA)
- By Application:
- Gene Expression
- Genotyping
- Other Usage
- Genome Cytogenetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Microarray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A DNA microarray is a type of genetic test that uses small pieces of DNA to identify specific genes. This technology can be used to study the effects of different drugs or treatments on individual cells or tissues.
Some of the major players in the dna microarray market are Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology, Savyon Diagnostics, Scienion AG, WaferGen.
The dna microarray market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DNA Microarray Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DNA Microarray Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DNA Microarray Market - Supply Chain
4.5. Global DNA Microarray Market Forecast
4.5.1. DNA Microarray Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DNA Microarray Market Size (000 Units) and Y-o-Y Growth
4.5.3. DNA Microarray Market Absolute $ Opportunity
5. Global DNA Microarray Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DNA Microarray Market Size and Volume Forecast by Type
5.3.1. Oligonucleotide DNA Microarrays (oDNA)
5.3.2. Complementary DNA Microarrays (cDNA)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DNA Microarray Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DNA Microarray Market Size and Volume Forecast by Application
6.3.1. Gene Expression
6.3.2. Genotyping
6.3.3. Other Usage
6.3.4. Genome Cytogenetics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DNA Microarray Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DNA Microarray Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DNA Microarray Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DNA Microarray Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DNA Microarray Demand Share Forecast, 2019-2026
9. North America DNA Microarray Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DNA Microarray Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DNA Microarray Market Size and Volume Forecast by Application
9.4.1. Gene Expression
9.4.2. Genotyping
9.4.3. Other Usage
9.4.4. Genome Cytogenetics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DNA Microarray Market Size and Volume Forecast by Type
9.7.1. Oligonucleotide DNA Microarrays (oDNA)
9.7.2. Complementary DNA Microarrays (cDNA)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DNA Microarray Demand Share Forecast, 2019-2026
10. Latin America DNA Microarray Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DNA Microarray Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DNA Microarray Market Size and Volume Forecast by Application
10.4.1. Gene Expression
10.4.2. Genotyping
10.4.3. Other Usage
10.4.4. Genome Cytogenetics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DNA Microarray Market Size and Volume Forecast by Type
10.7.1. Oligonucleotide DNA Microarrays (oDNA)
10.7.2. Complementary DNA Microarrays (cDNA)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DNA Microarray Demand Share Forecast, 2019-2026
11. Europe DNA Microarray Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DNA Microarray Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DNA Microarray Market Size and Volume Forecast by Application
11.4.1. Gene Expression
11.4.2. Genotyping
11.4.3. Other Usage
11.4.4. Genome Cytogenetics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DNA Microarray Market Size and Volume Forecast by Type
11.7.1. Oligonucleotide DNA Microarrays (oDNA)
11.7.2. Complementary DNA Microarrays (cDNA)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Pojections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DNA Microarray Demand Share, 2019-2026
12. Asia Pacific DNA Microarray Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DNA Microarray Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DNA Microarray Market Size and Volume Forecast by Application
12.4.1. Gene Expression
12.4.2. Genotyping
12.4.3. Other Usage
12.4.4. Genome Cytogenetics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DNA Microarray Market Size and Volume Forecast by Type
12.7.1. Oligonucleotide DNA Microarrays (oDNA)
12.7.2. Complementary DNA Microarrays (cDNA)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DNA Microarray Demand Share, 2019-2026
13. Middle East & Africa DNA Microarray Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DNA Microarray Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DNA Microarray Market Size and Volume Forecast by Application
13.4.1. Gene Expression
13.4.2. Genotyping
13.4.3. Other Usage
13.4.4. Genome Cytogenetics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DNA Microarray Market Size and Volume Forecast by Type
13.7.1. Oligonucleotide DNA Microarrays (oDNA)
13.7.2. Complementary DNA Microarrays (cDNA)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DNA Microarray Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DNA Microarray Market: Market Share Analysis
14.2. DNA Microarray Distributors and Customers
14.3. DNA Microarray Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumnia
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Affymetrix
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche NimbleGen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sengenics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Arrayit
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Applied Microarrays
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biometrix Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Savyon Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Scienion AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. WaferGen
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
